Skip to content

To Examine Safety and Efficacy of 525nm Multispot Green Laser and compare It with 532nm Multispot Green Laser In Retinal Disorders

A Prospective Comparative Study To Evaluate The Safety And Efficacy Of Aurolab’s Multispot Green Laser 525nm vs Iridex’s Pascal’s (532nm) Multispot Green Laser In Photocoagulation In Retinal Disorders - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096447
Enrollment
170
Registered
2025-10-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H356- Retinal hemorrhage

Interventions

Intervention1: 525nm Multispot Green Laser: An ophthalmic Multispot green laser system designed to emit a 525nm wavelength for photocoagulation. Delivers a stable and accurate 525nm wavelength output,

Sponsors

Aurolab
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients more than 18 years of age 2.Clear Cornea 3.Clear intraocular media 4.Intraocular pressure less than 20 mmHg 5.Well dilating pupil 6.Both eyes with clear proliferative Diabetic Retinopathy requiring laser photocoagulation 7.Patients willing to give written consent 8.Patients willing to come for follow up

Exclusion criteria

Exclusion criteria: 1.Advanced PDR 2.Clinically Significant Macular Edema (CSME) 3.Nephropathy (Creatinine greater than 2.0 mgs, Urea greater 55 mgs) 4.Uncontrolled hypertension 5.Patients require more than two sessions of laser photocoagulation. 6.Patients who had undergone previous laser photocoagulation 7.Patients who have undergone any previous vitreoretinal surgery 8.Eyes with media opacities not allowing proper fundus photography or adequate laser photocoagulation (Cataract, Corneal opacity, Dense vitreous hemorrhage, etc.,) 9.Those who are not willing for examinations, laser treatment and follow up visits.

Design outcomes

Primary

MeasureTime frame
Regression of retinopathy, pigmentation of burn, visual outcome after PRP laser treatmentTimepoint: Preop Day 15 post operatively Day 30 post operatively Day 90 post operatively

Secondary

MeasureTime frame
1.Visual outcome after PRP laser treatment 2.No lateral spreading and collateral damage, pain scoreTimepoint: 0 Day 15 1 Month 3 Month

Countries

India

Contacts

Public ContactDr A Syed Mohideen Abdul Khadar MS

Aravind Eye Hospital

syedmohideen@aravind.org9894849765

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026